Axsome Therapeutics(MX:AXSM)
MX$1,519.000.00 (0.00%)
MX:AXSM
Axsome Therapeutics earnings date
MX$1,519.00
At close:0.00 (0.00%)
Axsome Therapeutics (AXSM) Q2 2019 Earnings Report
1 Followers
MX:AXSM Q2 2019 EPS Results
- Actual EPS
- -MXN 7.63
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 5.95
MX:AXSM Q2 2019 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/08/2019
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2019
MX:AXSM Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AXSM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.89- | -10.42 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -11.79-4.65 | -17.48 | 73.40% (+12.83) | |
| Aug 10, 2026 | 2026 (Q2) | -16.59-18.41 | -18.04 | -2.06% (-0.37) | |
| May 04, 2026 | 2026 (Q1) | -15.70-23.44 | -22.69 | -3.28% (-0.74) | |
| Feb 23, 2026 | 2025 (Q4) | -12.91-10.42 | -28.64 | 63.64% (+18.23) | |
| Nov 03, 2025 | 2025 (Q3) | -16.01-17.48 | -24.92 | 29.85% (+7.44) | |
| Aug 04, 2025 | 2025 (Q2) | -19.62-18.04 | -31.06 | 41.92% (+13.02) | |
| May 05, 2025 | 2025 (Q1) | -25.13-22.69 | -26.78 | 15.28% (+4.09) | |
| Feb 18, 2025 | 2024 (Q4) | -18.62-28.64 | -38.69 | 25.96% (+10.04) | |
| Nov 12, 2024 | 2024 (Q3) | -25.72-24.92 | -24.55 | -1.52% (-0.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
